Low-grade stage ILL-IV follicular lymphoma: Multivariate analysis of prognostic factors in 484 patients - A study of the groupe d'etude des lymphomes de l'adulte

Journal of Clinical Oncology

Volumn 17, Issue 8, 1999, Pages 2499-2505

  Decaudin, Didier ^a   Lepage, Eric ^a   Brousse, Nicole ^a   Brice, Pauline ^a   Harousseau, Jean Luc ^a   Belhadj, Karim ^a   Tilly, Hervé ^a   Michaux, Lucienne ^a   Chèze, Stéphane ^a   Coiffier, Bertrand ^a   Solal Céligny, Philippe ^a  

^a Belgium

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032772649     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.8.2499     Document Type: Article

References (26)

1. Bastion Y, Berger F, Bryon PA, et al: Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years. Ann Oncol 2:123-134, 1991 (suppl 2)
2. Rosenberg SA: The low-grade non-Hodgkin's lymphomas: Challenges and opportunities. J Clin Oncol 3:299-310, 1985
3. Leonard RCF, Hayward RL, Prescott RJ, et al: The identification of discrete prognostic groups in low-grade non-Hodgkin's lymphoma: The Scotland and Newcastle Lymphoma Group Therapy Working Party. Ann Oncol 2:655-662, 1991
4. Romaguera JE, Mc Laughlin P, North L, et al: Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model. J Clin Oncol 9:762-769, 1991
5. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma: The International NHL Prognostic Factors Project. N Engl J Med 329:987-994, 1993
6. Freedman AS, Takvorian T, Neuberg D, et al: Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission. J Clin Oncol 11:931-936, 1993
7. Maloney DG, Grillo-Lopez AJ, Bodkin DJ, et al: IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol 15:3266-3274, 1997
8. Brice P, Bastion Y, Lepage E, et al: Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: A randomized study from the Groupe d'Etude des Lymphomes Folliculaires. J Clin Oncol 15:1110-1117, 1997
9. Solal-Céligny P, Lepage E, Brousse N, et al: Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: Final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 trial. J Clin Oncol 16:2332-2338, 1998
10. Rudders RA, Kadin M, De Lellis RA, et al: Nodular non-Hodgkin's lymphoma: Factors influencing prognosis and indications for aggressive treatment. Cancer 43:1643-1651, 1979
11. Anderson T, De Vita VT, Simon R, et al: Malignant lymphoma II: Prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer 50:2708-2721, 1982
12. Gallacher CJ, Gregory WM, Jones AE, et al: Follicular lymphoma: Prognostic factors for response and survival. J Clin Oncol 4:1470-1480, 1986
13. Ezdinli EZ, Costello WG, Kucuk O, et al: Effect of the degree of nodularity on the survival of patients with nodular lymphomas. J Clin Oncol 5:413-418, 1987
14. Steward WF, Crowther D, Mc William LJ, et al: Maintenance chlorambucil after CVP in the management of advenced stage, low-grade histologic type non-Hodgkin's lymphoma. Cancer 61:441-447, 1988
15. Lepage E, Sebban C, Gisselbrecht C, et al: Treatment of low-grade non-Hodgkin's lymphoma: Assessment of doxorubicin in a controlled trial. Hematol Oncol 8:31-39, 1990
16. Litam P, Swan F, Cabanillas F, et al: Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Am J Med 114:855-860, 1991
17. Soubeyran P, Eghbali H, Bonichon F, et al: Low-grade follicular lymphomas: Analysis of prognosis in a series of 281 patients. Eur J Cancer 27:1606-1613, 1991
18. Cameron DA, Leonard RCF, Mao J-H, et al: Identification of prognostic groups in follicular lymphoma. Leuk Lymphoma 10:89-99, 1993
19. Gospodarowicz MK, Bush RS, Brown TC, et al: Prognostic factors in nodular lymphomas: A multi-variate analysis based on the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 10:489-492, 1994
20. Denham JW, Denham E, Dear KB, et al: The follicular non-Hodgkin's lymphomas II: Prognostic factors - What do they mean? Eur J Cancer 32A:480-490, 1996
21. Avilès A: The International Index is not useful in the classification of low-grade lymphoma. J Clin Oncol 12:2766-2770, 1994
22. Bastion Y, Coiffier B: Is the International Prognostic Index for aggressive lymphoma patients useful for follicular lymphoma patients? J Clin Oncol 12:1340-1342, 1994
23. Martin AR, Weisenburger DD, Chan WC, et al: Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 85:3671-3678, 1995
24. Hermans J, Krol ADG, van Groningen K, et al: International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood 86:1460-1463, 1995
25. Lopez-Guillermo A, Montserrat E, Bosch F, et al: Applicability of the International Prognostic Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 12:1343-1348, 1994
26. The non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89:3909-3918, 1997